SCHEMBL722812

SCHEMBL722812

C=CCC(C)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6717947 0.80
SCHEMBL2527358 0.79 GRIK1 (0.35)
SCHEMBL23328241 0.78 TSHR (0.32)
SCHEMBL19193439 0.77
SCHEMBL7437585 0.77
SCHEMBL3610549 0.77
SCHEMBL1246863 0.77
SCHEMBL12972243 0.77
SCHEMBL2536422 0.77
SCHEMBL1031922 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4426705-A1 CYCLOHEPTA-THIENO-DIAZEPINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE GABA A GAMMA1 RECEPTOR F. Hoffmann-La Roche AG (CH) 2024-09-11 EP claimed
WO-2023057423-A1 CYCLOHEPTA-THIENO-DIAZEPINE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE GABA A GAMMA1 RECEPTOR F. HOFFMANN-LA ROCHE AG (CH) 2023-04-13 WO claimed
CN-115894323-A Method for self-cyclizing cyanation of enaminoaniline compound 湖北工业大学 2023-04-04 CN claimed
EP-3340796-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI Foundation, Inc. (US) 2018-07-04 EP claimed
WO-2017040336-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. (US) 2017-03-09 WO claimed
WO-2016042172-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2016-03-24 WO claimed
EP-2976424-A1 STABILISATION OF BIOLOGICAL SAMPLES Qiagen GmbH (DE) 2016-01-27 EP claimed
WO-2014146781-A1 STABILISATION OF BIOLOGICAL SAMPLES QIAGEN GMBH (DE) 2014-09-25 WO claimed
US-20240239747-A1 Next Generation 5-HT2AR Agonists HUXLEY HEALTH, INC. (CA) 2024-07-18 US disclosed
WO-2023209449-A1 LIGHT-FILTERING MATERIALS FOR BIOMATERIAL INTEGRATION AND METHODS THEREOF JOHNSON & JOHNSON VISION CARE, INC. (US) 2023-11-02 WO disclosed
WO-2023209448-A1 THERMALLY STABLE NANOPARTICLES AND METHODS OF MAKING THEM JOHNSON & JOHNSON VISION CARE, INC. (US) 2023-11-02 WO disclosed
WO-2023209446-A1 SHAPE ENGINEERING OF PARTICLES TO CREATE A NARROW SPECTRAL FILTER AGAINST A SPECIFIC PORTION OF THE LIGHT SPECTRUM JOHNSON & JOHNSON VISION CARE, INC. (US) 2023-11-02 WO disclosed
WO-2023209447-A1 PARTICLE SURFACE MODIFICATION TO INCREASE COMPATIBILITY AND STABILITY IN HYDROGELS JOHNSON & JOHNSON VISION CARE, INC. (US) 2023-11-02 WO disclosed
WO-2023209450-A1 USING PARTICLES FOR LIGHT FILTERING JOHNSON & JOHNSON VISION CARE, INC. (US) 2023-11-02 WO disclosed
US-5185465-A Carboxamides of 2-amino-alpha-phenlphenethylamines HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1993-02-09 US disclosed
US-5008395-A Forming hydrochloride salt, removing excess hydrogen chloride, cooling until crystals form, ripening, filtering ROHM AND HAAS COMPANY (US) 1991-04-16 US disclosed
US-4968721-A 2-amino-alpha-phenylphenethylamines and method of use HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1990-11-06 US disclosed
EP-0375265-A2 Purification of isothiazolones ROHM AND HAAS COMPANY (US) 1990-06-27 EP disclosed
US-4525588-A FOR HEAT AND PRESSURE SENSITIVE RECORDING MATERIALS CIBA GEIGY CORPORATION (US) 1985-06-25 US disclosed
US-4203917-A MOLYBDATE OR MIXED OXIDE AMMOXIDATION CATALYST UNIBRA SOCIETE ANONYME (BE) 1980-05-20 US disclosed